Myriad Genetics
MYGN
#8500
Rank
$0.27 B
Marketcap
$2.86
Share price
-46.74%
Change (1 day)
-25.52%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -$0.39 Billion USD

According to Myriad Genetics's latest financial reports the company's current earnings are $0.82 Billion USD. In 2025 the company made an earning of -$0.39 Billion USD a decrease over its 2024 earnings that were of -$0.13 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.39 Billion0.36%
2025 -$0.39 Billion218.91%
2024 -$0.13 Billion-53.49%
2023 -$0.26 Billion88.72%
2022 -$0.14 Billion172.08%
2021 -$50.5 Million
2019 -$26.3 Million-175.14%
2018 $35 M-70.81%
2017 $0.11 B22.22%
2016 $98.1 M-38.8%
2015 $0.16 B-6.12%
2014 $0.17 B-41.07%
2013 $0.28 B46.67%
2012 $0.19 B15.84%
2011 $0.17 B17.6%
2010 $0.14 B-15.96%
2009 $0.17 B
2007 -$41.68 Million40.96%
2006 -$29.57 Million
2003 -$34.34 Million34.8%
2002 -$25.48 Million89.21%
2001 -$13.47 Million3.93%
2000 -$12.96 Million21.76%
1999 -$10.64 Million-25.61%
1998 -$14.3 Million38.83%
1997 -$10.3 Million-24.26%
1996 -$13.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
$8.13 B-2,208.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-$0.19 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38 B-199.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-$34.97 Million-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
$0.22 B-157.59%๐Ÿ‡บ๐Ÿ‡ธ USA